A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ACTG2 | Actin, gamma 2, smooth muscle, enteric | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AIM1L | Absent in melanoma 1-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDOC | Aldolase C, fructose-bisphosphate | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALPPL2 | Alkaline phosphatase, placental-like 2 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
AMOT | Angiomotin | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APBB3 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOLD1 | Apolipoprotein L domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |